12399456https://www.upal.com.my/zh/feeds/jobFeedKwongwahArray ( [0] => HTTP/1.1 200 OK [1] => Date: Sun, 23 Nov 2025 18:28:23 GMT [2] => Content-Type: text/xml; charset=utf-8 [3] => Connection: close [4] => Cache-Control: no-cache, private [5] => Cache-Control: no-cache, no-store, must-revalidate [6] => Nel: {"report_to":"cf-nel","success_fraction":0.0,"max_age":604800} [7] => x-frame-options: SAMEORIGIN [8] => x-content-type-options: nosniff [9] => x-xss-protection: 1; mode=block [10] => referrer-policy: strict-origin-when-cross-origin [11] => permissions-policy: geolocation=(), microphone=(), camera=() [12] => content-security-policy: default-src * 'unsafe-inline' 'unsafe-eval' data: blob:; script-src * 'unsafe-inline' 'unsafe-eval' data: blob:; style-src * 'unsafe-inline' data:; img-src * data: blob:; font-src * data:; connect-src *; frame-src *; object-src *; media-src *; child-src *; [13] => Server: cloudflare [14] => x-robots-tag: noindex, nofollow, nosnippet, noarchive [15] => strict-transport-security: max-age=31536000; includeSubDomains; preload [16] => expires: Mon, 24 Nov 2025 18:28:23 GMT [17] => vary: Accept-Encoding [18] => Report-To: {"group":"cf-nel","max_age":604800,"endpoints":[{"url":"https://a.nel.cloudflare.com/report/v4?s=5JeTr5eZZQ7chGvBCMZ9Y2cQjuZrhMFs%2FAMCUSrdLxEvdQSEXQEJSPPD0AqjU332490qUk64kq71Y3eI4ar%2FlKA74FBPcoZbkZirWXU%3D"}]} [19] => cf-cache-status: DYNAMIC [20] => Speculation-Rules: "/cdn-cgi/speculation" [21] => Server-Timing: cfCacheStatus;desc="DYNAMIC" [22] => Server-Timing: cfEdge;dur=3,cfOrigin;dur=117 [23] => Set-Cookie: UpalLiveSession=eyJpdiI6Ing1OWg2WCtCVFNBTFdpd05IY0Y4XC9nPT0iLCJ2YWx1ZSI6IngxcXVUT2orTFNlMmRxTFB4YUs5ellVUTFiVHdBU2p6REsxOFwveEtNTEdhRjBQUlErMEROOEJjYkswQzVZRVM5ckY4d1h0ZVhQalVTRWFERm9tOU83Zz09IiwibWFjIjoiZTk1MGE4N2U3ZTNlOWE4N2YwMTBlM2I4ZDJiMzllMGYzNjcyYWQzNDBiNzM4ZDBjZGJkMDk4MDcxYWRlNmY0NSJ9; HttpOnly; Path=/; Max-Age=94608000; Expires=Wed, 22 Nov 2028 18:28:23 GMT [24] => CF-RAY: 9a32b9dedc9b7a7f-KUL [25] => alt-svc: h3=":443"; ma=86400 ) 789

美国吉利德科学公司研发的药物“瑞德西韦”，被认为可望抑制新型冠状病毒感染，中国科学家于周三已在武汉启动临床试验，用于治疗新冠肺炎患者。

媒体报导，主导瑞德西韦研发工作的是来自台湾的女科学家，也就是吉利德制药部门执行副总裁杨台莹。

根据吉利德网站介绍，杨台莹毕业于台湾大学化学系，也拥有南加州大学有机化学博士学位。

她领导吉利德的药物研发与制造部门，负责该公司研发与上市产品。在她的领导下，吉利德研发出全球第一款治疗HIV单锭药物，也将多于25种复方制剂研发成药品。

北京“中日友好医院”的王辰、曹彬团队于周三下午在武汉市金银潭医院宣布启动瑞德西韦治疗2019新型冠状病毒感染临床3期研究，首批试验761位患者。